v3.26.1
Discontinued Operations - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Oct. 28, 2024
Jan. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Gain (loss) on sale of interest in subsidiary     $ 0 $ 376,506 $ 0
Gain on deconsolidation     $ 11,027 3,108 32,772
Discontinued Operations, Disposed of by Sale | Dermavant          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Receivable from sale of discontinued operations $ 175,000        
Milestone receivable from sale of discontinued operations 75,000     75,000  
Sale milestone receivable from sale of discontinued operations 950,000        
Net sales $ 1,000,000        
Percentage of annual net sales 30.00%        
Percentage of liquidation preference receivable 100.00%        
Consideration receivable under liquidation preference $ 270,000        
Cash received 183,600        
Milestone received from sale of discontinued operations   $ 75,000      
Gain (loss) on sale of interest in subsidiary       376,506 $ 0
Gain on deconsolidation       $ 301,500  
Discontinued Operations, Disposed of by Sale | Dermavant | Maximum          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Net sales $ 1,000,000